Alsfouk, A.A.; Alshibl, H.M.; Alsfouk, B.A.; Altwaijry, N.A.; Al-Abdullah, E.S.
Synthesis and Biological Evaluation of Imadazo[1,2-a]pyrazines as Anticancer and Antiviral Agents through Inhibition of CDK9 and Human Coronavirus. Pharmaceuticals 2022, 15, 859.
https://doi.org/10.3390/ph15070859
AMA Style
Alsfouk AA, Alshibl HM, Alsfouk BA, Altwaijry NA, Al-Abdullah ES.
Synthesis and Biological Evaluation of Imadazo[1,2-a]pyrazines as Anticancer and Antiviral Agents through Inhibition of CDK9 and Human Coronavirus. Pharmaceuticals. 2022; 15(7):859.
https://doi.org/10.3390/ph15070859
Chicago/Turabian Style
Alsfouk, Aisha A., Hanan M. Alshibl, Bshra A. Alsfouk, Najla A. Altwaijry, and Ebtehal S. Al-Abdullah.
2022. "Synthesis and Biological Evaluation of Imadazo[1,2-a]pyrazines as Anticancer and Antiviral Agents through Inhibition of CDK9 and Human Coronavirus" Pharmaceuticals 15, no. 7: 859.
https://doi.org/10.3390/ph15070859
APA Style
Alsfouk, A. A., Alshibl, H. M., Alsfouk, B. A., Altwaijry, N. A., & Al-Abdullah, E. S.
(2022). Synthesis and Biological Evaluation of Imadazo[1,2-a]pyrazines as Anticancer and Antiviral Agents through Inhibition of CDK9 and Human Coronavirus. Pharmaceuticals, 15(7), 859.
https://doi.org/10.3390/ph15070859